Real-time enrollment status for this based on the study title mentioning efad (essential fatty acid deficiency) and pnac (parenteral nutrition associated cholestasis), and the use of lipid injectable emulsion, the primary patient-facing condition is: nutritional deficiency clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT06049680 |
| Recruiting Status | Recruiting |
| Condition | Based on the study title mentioning EFAD (Essential Fatty Acid Deficiency) and PNAC (Parenteral Nutrition Associated Cholestasis), and the use of lipid injectable emulsion, the primary patient-facing condition is: Nutritional Deficiency |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Fresenius Kabi |
| Last Updated on CT.gov | December 4, 2025 (Dec 4, 2025) |
As of March 2, 2026: Clinical trial NCT06049680 is currently recruiting participants. This clinical trial study for based on the study title mentioning efad (essential fatty acid deficiency) and pnac (parenteral nutrition associated cholestasis), and the use of lipid injectable emulsion, the primary patient-facing condition is: nutritional deficiency is actively seeking new participants at 4 locations across the United States. The study is sponsored by Fresenius Kabi. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06049680 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06049680 was last updated Dec 4, 2025 (December 4, 2025). HelloStudys verifies this status automatically.